Xcout Intel
Ausperbio
Ausperbio is a clinical-stage biopharmaceutical company dedicated to transforming hepatitis B virus (HBV) treatment for a cure and advancing oligonucleotide therapeutics.
The full profile of Ausperbio
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Ausperbio →Already a subscriber? Sign in
Xcout Intel tracks Ausperbio continuously — this profile deepens as new filings, funding, people and hiring data arrive.